PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Baylor Scott & White Research Institute, Baylor Scott and White Health, Dallas, Texas, USA.\', \'Center for Advanced Heart and Lung Disease, Baylor University Medical Center, Dallas, Texas, USA.\', \'Baylor Annette C and Harold C Simmons Transplant Institute, Baylor Scott and White Health, Dallas, Texas, USA.\', \'College of Medicine, Texas A&M Health Science Center, Texas A&M University, Dallas, Texas, USA.\', \'Division of Infectious Disease, Baylor University Medical Center, Dallas, Texas, USA.\', \'Texas Centers for Infectious Disease Associates, Dallas, Texas, USA.\', \'Baylor Scott & White Research Institute, Baylor Scott and White Health, Dallas, Texas, USA robert.gottlieb@bswhealth.org.\', \'Division of Precision Medicine, Baylor University Medical Center, Dallas, Texas, USA.\', \'Department of Internal Medicine, TCU and UNTHSC School of Medicine, Fort Worth, Texas, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1136/jim-2020-001525
?:doi
?:hasPublicationType
?:journal
  • Journal of investigative medicine : the official publication of the American Federation for Clinical Research
is ?:pmid of
?:pmid
?:pmid
  • 33431604
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • ALLY in fighting COVID-19: magnitude of albumin decline and lymphopenia (ALLY) predict progression to critical disease.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all